Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.37 | N/A |
| PEG Ratio (TTM) | -0.44 | N/A |
| P/S Ratio (TTM) | 3.92 | N/A |
| P/B Ratio (TTM) | 1.50 | N/A |
| P/FCF Ratio (TTM) | 18.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.42 | N/A |
| Price to 5YR AVG FCF Ratio | 52.68 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.90% | N/A |
| ROE (TTM) | 5.11% | N/A |
| Net Profit Margin (TTM) | 3.14% | N/A |
| ROIC 5YR AVG | 10.84% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.77% | -4.33% | 0.48% |
| Revenue | -8.10% | 15.21% | 34.16% |
| Net Income | 4.04% | -19.40% | -5.12% |
| Cash Flow | 67.70% | -15.08% | 3.35% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.12 | N/A |
| Quick Ratio (TTM) | 4.12 | N/A |
| D/E Ratio (TTM) | 1.03 | N/A |
| Interest Coverage (TTM) | 2.97 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.65 | N/A |
| LTL to 5YR AVG FCF | 11.51 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.38% | N/A |